StephanieLynn(Schutt)GraffMD

Oncology • Kansas City, MO

Breast Cancer, Hematologic Oncology

Physician

Join to view full profile

Dr. Graff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Graff's full profile

Already have an account?

Office
2316 E Meyer Blvd
1 Cancer West
Kansas City, MO 64132
Phone+1 816-276-4700

Fax+1 816-276-3810

Education & Training

University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 2004 - 2007
University of Missouri Kansas City School of MedicineClass of 2004

Certifications & Licensure

RI State Medical License 2021 - 2026
KS State Medical License 2008 - 2021
MO State Medical License 2006 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread Start of enrollment: 2018 Nov 28
Completed
Phase 2

Publications & Presentations

PubMed

New Emerging Therapies Targeting PI3K/AKT/mTOR/PTEN Pathway in Hormonal Receptor-Positive and HER2-Negative Breast Cancer-Current State and Molecular Pathology Perspec...
Liu Liu, Stephanie L Graff, Yihong Wang
Cancers. 2024-12-24
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial.
Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, Stephanie L Graff, Kyong Hwa Park
Journal of Clinical Oncology. 2024-12-18
Recent advancements in biomarkers and molecular diagnostics in hormonal receptor-positive breast cancer.
Yihong Wang, Liu Liu, Stephanie L Graff, Liang Cheng
Histopathology. 2024-12-17

Abstracts/Posters

WhatÍs in a Name? a Gender-Based Analysis of Speaker Introductions at the American Society of Hematology Annual Meeting
Stephanie L. Graff, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

How Close Is Too Close: Navigating Difficult Situations
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

The Oncology Brothers Advancements in Oncology: What Community Oncologists Can Bring to Their Practice of Breast CancerJanuary 7th, 2025
Muddier Waters and an FDA Approval? Phase 3 Imlunestrant Data May Shake Up Breast Cancer CareJanuary 3rd, 2025
Phase 3 Palbociclib Data Are “Immediately Practice-Changing” in Advanced Breast CancerJanuary 2nd, 2025
Join now to see all